London digital pathology conference returns to in-person format

Article • 8th Digital Pathology and AI Congress

London digital pathology conference returns to in-person format

More than 50 leading digital pathology experts have been lined up for a major conference in London in December looking at all aspects of the field.

Speakers will explore latest developments, new trends, challenges, and innovation, as well as the effects of Covid-19 on pathology practice, during the 8th Digital Pathology and AI Congress on December 1 and 2. Artificial intelligence will feature strongly, and its application in a number of solutions, as well as telepathology, clinical trials and workflows.

Significantly, it marks a return to face-to-face presentations after the 2020 event moved online. Nick Noakes, Head of Marketing with organisers Global Engage, said: “We are really excited to back to holding the meeting as an in-person event. “The meeting sold out in 2019, and although not everyone is ready to come back to live meetings, our research suggests many are. Plus, we have the support of the speakers and sponsors who also think the time is right. Networking is the heart of this meeting and we will be working hard to provide a safe and engaging environment to make this happen.” The congress will be held at the London Heathrow Marriott on December 1-2, with more than 450 participants and 40+ exhibitors.

The programme for 2021 covers many aspects of Digital Pathology and AI and has tracks dedicated to digital image analysis, computational pathology, implementation strategy and workflow as well as application of the technology in a biopharma setting

Mike Burden

The organisers say the London event will showcase some of the most exciting cutting-edge strategies and analysis techniques as well as important issues related to implementation and daily use in the era of Covid-19. It will also explore the continued advances in artificial intelligence and image analysis tools so that digital pathology can be utilized to its full potential. In addition, there will be a dedicated track which focuses on the use of digital pathology in drug discovery with a focus on both clinical and non-clinical applications.

With over 55 presentations from an expert speaker faculty, panel discussion sessions, poster presentations and vendor workshops, there will also be a pre-conference workshop on November 30 which will provide a hands-on experience with technologies and software. 

Mike Burden, Head of Conferences at Global Engage, said: “The programme for 2021 covers many aspects of Digital Pathology and AI and has tracks dedicated to digital image analysis, computational pathology, implementation strategy and workflow as well as application of the technology in a biopharma setting.”

Among the speakers are Professor Jo Martin, Professor of Pathology at Queen Mary University of London, whose opening keynote address will focus on the “the pathology workforce for a digital future”; Viktor Koelzer, Assistant Professor and Lead for Digital Pathology, University of Zürich, who will examine “molecular classification of colorectal cancer by image analysis and artificial intelligence”; and David Snead, Consultant pathologist at University Hospitals Coventry and Warwickshire NHS Trust, who will discuss “quality management and ISO 15189 compliance for digital whole slide imaging in histopathology laboratories.”

Other speakers include Darren Treanor (Leeds), Pierre Moulin (Novartis), and Nathalie Fiaschi (Regeneron), with Indica, Corista, Dell, Sectra and Nanostring among the exhibitors. (MN)


*For more information and booking, call Maria Mirnova, +44 (0) 1865 671957 ext. 207 or maria@globalengage.co.uk. For the full agenda and online bookings, visit www.global-engage.com/event/digital-pathology/

15.09.2021

Read all latest stories

Related articles

Photo

News • Lung cancer

A novel AI for digital pathology analysis

Researchers from Boston University School of Medicine have developed a novel artificial intelligence algorithm to assess digital pathology data.

Photo

Article • Detection and diagnosis of cancer

The ‘smart’ future of cytology

A combination of digital pathology and quantitative biomarker analysis in the emerging concept of ‘smart’ cytology has a potential role in the detection and diagnosis of cancer.

Photo

Article • Experience report from Portugal

Going digital: no reason to delay

The future of pathology is digital – for many departments, transformation requires major modifications but promises significant advantages. Professor Catarina Eloy outlines the vital elements.

Related products

Fujifilm – Dynamyx

Pathology

Fujifilm – Dynamyx

FUJIFILM Europe GmbH
Agfa HealthCare – Rubee for AI

Artificial Intelligence

Agfa HealthCare – Rubee for AI

Agfa HealthCare
Canon – Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon – Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Canon - Aquilion Exceed LB

Oncology CT

Canon - Aquilion Exceed LB

Canon Medical Systems Europe B.V.
Canon – Aquilion Lightning

20 to 64 Slices

Canon – Aquilion Lightning

Canon Medical Systems Europe B.V.
Canon – Aquilion Lightning SP

Volume CT

Canon – Aquilion Lightning SP

Canon Medical Systems Europe B.V.
Subscribe to Newsletter